TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medical Developments International Limited ( (AU:MVP) ) just unveiled an announcement.
Medical Developments International Limited announced a change in the director’s interest, with Director Mark Fladrich acquiring 62,858 fully paid ordinary shares on the market as of September 30, 2025. This acquisition reflects a strategic move that could impact the company’s market positioning and stakeholder interests, highlighting the director’s confidence in the company’s future prospects.
The most recent analyst rating on (AU:MVP) stock is a Buy with a A$0.80 price target. To see the full list of analyst forecasts on Medical Developments International Limited stock, see the AU:MVP Stock Forecast page.
More about Medical Developments International Limited
Medical Developments International Limited operates in the medical industry, focusing on the development and distribution of innovative healthcare solutions. The company is known for its products and services that cater to medical professionals and patients, enhancing healthcare delivery and patient outcomes.
Average Trading Volume: 150,266
Technical Sentiment Signal: Buy
Current Market Cap: A$78.86M
For detailed information about MVP stock, go to TipRanks’ Stock Analysis page.